The National Institute for Clinical Excellence has published guidelines for support available, diagnosis and management of bladder cancer in patients. This information is intended for clinical professionals, but can also be referenced by patients and carers over the age of 18. The guidelines support the staging of bladder cancer and following up non-muscle invasive bladder cancer and muscle invasive bladder cancer. Specialist palliative care is also covered, in order to help support people who are incurable.

 

The NICE bladder cancer guidelines explain that bladder cancer is one of the 10 most common in the UK, and most predominant in men over 60. The purpose of the bladder is to store urine before it is passed out of the body, and is made up of three layers. These include an inner lining, the muscle wall and a thin connective tissue layer between these two. Bladder cancer occurs when abnormal tissue grows in the lining, which can then affect the muscle wall.

 

This guideline offers evidence-based advice on the diagnosis and management of bladder cancer in adults (18 years and older) referred from primary care with suspected bladder cancer, and those with newly diagnosed or recurrent bladder (urothelial carcinoma, adenocarcinoma, squamous-cell carcinoma or small-cell carcinoma) or urethral cancer.

 

This guideline includes recommendations on information and support for people with bladder cancer, including diagnosing and staging bladder cancer, and the different treatments available.

 

To find out more please visit the NICE website.

Skip to content